This page has not been authorized, sponsored, or otherwise approved or endorsed by the companies represented herein. Each of the company logos represented herein are trademarks of Microsoft Corporation; Dow Jones & Company; Nasdaq, Inc.; Forbes Media, LLC; Investor's Business Daily, Inc.; and Morningstar, Inc.
Copyright 2024 Zacks Investment Research | 10 S Riverside Plaza Suite #1600 | Chicago, IL 60606
At the center of everything we do is a strong commitment to independent research and sharing its profitable discoveries with investors. This dedication to giving investors a trading advantage led to the creation of our proven Zacks Rank stock-rating system. Since 1988 it has more than doubled the S&P 500 with an average gain of +24.10% per year. These returns cover a period from January 1, 1988 through October 7, 2024. Zacks Rank stock-rating system returns are computed monthly based on the beginning of the month and end of the month Zacks Rank stock prices plus any dividends received during that particular month. A simple, equally-weighted average return of all Zacks Rank stocks is calculated to determine the monthly return. The monthly returns are then compounded to arrive at the annual return. Only Zacks Rank stocks included in Zacks hypothetical portfolios at the beginning of each month are included in the return calculations. Zacks Ranks stocks can, and often do, change throughout the month. Certain Zacks Rank stocks for which no month-end price was available, pricing information was not collected, or for certain other reasons have been excluded from these return calculations. Zacks may license the Zacks Mutual Fund rating provided herein to third parties, including but not limited to the issuer.
Visit Performance Disclosure for information about the performance numbers displayed above.
Visit www.zacksdata.com to get our data and content for your mobile app or website.
Real time prices by BATS. Delayed quotes by Sungard.
NYSE and AMEX data is at least 20 minutes delayed. NASDAQ data is at least 15 minutes delayed.
This site is protected by reCAPTCHA and the Google Privacy Policy, DMCA Policy and Terms of Service apply.
Zacks News
Sprouts Farmers Hits 52-Week High: What Should be Your Move?
by Zacks Equity Research
SFM capitalizes on the rising demand for healthy, organic and natural products, aligning with the evolving consumer shift toward wellness and sustainability.
Why EL Stock Is Under Pressure: Key Issues to Watch In Fiscal 2025
by Zacks Equity Research
EL faces mounting pressure in its Asia-Pacific markets, shifting consumer behavior and currency headwinds, raising concerns for the fiscal 2025 outlook.
Is HSY Stock's 3.4X P/S Still Worth It? Time to Buy, Sell or Hold?
by Zacks Equity Research
Despite Hershey's strategic focus, a challenging macroeconomic landscape and high input costs raise concerns.
Is Campbell Soup Stock a Buy or Hold at a P/E Multiple of 14.7X?
by Zacks Equity Research
CPB's focus on innovation, portfolio reshaping and maintaining affordability positions it well for growth. Yet, cost inflation and Snacks unit hurdles remain.
Is Mondelez Stock a Buy, Hold or Sell at a P/E Multiple of 20.3X?
by Zacks Equity Research
While MDLZ's growth initiatives and market positioning are promising, cost inflation and the current economic environment raise concerns.
Is TreeHouse Foods Stock a Buy or Hold at a P/E Multiple of 14.3X?
by Zacks Equity Research
THS' transformation journey is poised for success as it focuses on strengthening its presence in the snacking and beverage sectors.
LW Q1 Earnings Meet Estimates, Profit View Cut Amid Demand Slowdown
by Zacks Equity Research
Lamb Weston's first-quarter fiscal 2025 results reflect lower earnings amid soft restaurant traffic and frozen potato demand.
Is KHC's Pricing Strategy Enough to Sustain Growth Amid Challenges?
by Zacks Equity Research
Kraft Heinz is maintaining profitability through effective pricing strategies and operational agility despite facing challenges from declining consumer demand.
McCormick Q3 Earnings Top Estimates, MKC Volumes Improve Y/Y
by Zacks Equity Research
McCormick's Q3 results reflect positive volume growth, indicating improving trends across both business segments.
McCormick (MKC) Q3 Earnings: Taking a Look at Key Metrics Versus Estimates
by Zacks Equity Research
While the top- and bottom-line numbers for McCormick (MKC) give a sense of how the business performed in the quarter ended August 2024, it could be worth looking at how some of its key metrics compare to Wall Street estimates and year-ago values.
McCormick (MKC) Surpasses Q3 Earnings and Revenue Estimates
by Zacks Equity Research
McCormick (MKC) delivered earnings and revenue surprises of 22.06% and 0.94%, respectively, for the quarter ended August 2024. Do the numbers hold clues to what lies ahead for the stock?
Kimberly-Clark Stock Trading Above 200 & 50-Day SMA: Should You Buy?
by Zacks Equity Research
KMB is demonstrating strong market resilience and growth with a volume-plus-mix approach, ongoing transformation and investments in innovation and efficiency.
Tyson Foods' Operational Strategies Aid Amid Beef Segment Hurdles
by Zacks Equity Research
TSN's operational excellence, customer and consumer obsession, and Chicken unit strength keep it well-positioned amid Beef unit challenges.
Why Investors Should Watch COTY Stock Amid Booming Beauty Industry?
by Zacks Equity Research
Coty is capitalizing on the growing beauty market via strategic expansion in consumer beauty and fragrances, innovation and e-commerce growth.
Insights Into McCormick (MKC) Q3: Wall Street Projections for Key Metrics
by Zacks Equity Research
Evaluate the expected performance of McCormick (MKC) for the quarter ended August 2024, looking beyond the conventional Wall Street top-and-bottom-line estimates and examining some of its key metrics for better insight.
Why McCormick (MKC) Could Beat Earnings Estimates Again
by Zacks Equity Research
McCormick (MKC) has an impressive earnings surprise history and currently possesses the right combination of the two key ingredients for a likely beat in its next quarterly report.
McCormick Gears Up for Q3 Earnings Release: Things to Keep in Mind
by Zacks Equity Research
MKC's strong momentum and effective growth strategies might be overshadowed by rising expenses, soft volume trends and currency risks in its Q3 performance.
What's Ahead for Inter Parfums in the Booming Fragrance Market?
by Zacks Equity Research
IPAR is leveraging positive fragrance market trends and strong new licenses amid an elevated cost environment.
Analysts Estimate Conagra Brands (CAG) to Report a Decline in Earnings: What to Look Out for
by Zacks Equity Research
Conagra Brands (CAG) doesn't possess the right combination of the two key ingredients for a likely earnings beat in its upcoming report. Get prepared with the key expectations.
Why McCormick (MKC) is a Top Momentum Stock for the Long-Term
by Zacks Equity Research
The Zacks Style Scores offers investors a way to easily find top-rated stocks based on their investing style. Here's why you should take advantage.
Sysco's Secret Sauce: How SYY Stock is Positioned for Growth
by Zacks Equity Research
Sysco's focus on operational efficiency, customer support and its Recipe for Growth plan positions it well for long-term success despite challenges.
McCormick (MKC) Earnings Expected to Grow: What to Know Ahead of Next Week's Release
by Zacks Equity Research
McCormick (MKC) doesn't possess the right combination of the two key ingredients for a likely earnings beat in its upcoming report. Get prepared with the key expectations.
Mondelez Stock Trading Above 200 & 50-Day SMA: How to Play Ahead?
by Zacks Equity Research
Mondelez is gaining on pricing initiatives, cost control and a focus on core categories, while high cocoa prices and inflationary pressures raise concerns.
Sprouts Farmers Trades Near 52-week High: Should You Buy SFM?
by Zacks Equity Research
SFM continues to witness an upward trend, fueled by growth and innovation, as well as its commitment to operational efficiency and digital initiatives.
Nu Skin Trading Near 52-Week Low: Should You Buy or Sell NUS Stock?
by Zacks Equity Research
Nu Skin is facing macroeconomic difficulties and a slow-moving direct-selling market. Foreign currency headwinds are also weighing on NUS.